Phosphodiesterase-3 inhibition augments the myocardial infarct size-limiting effects of exenatide in mice with type 2 diabetes.
about
Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases.Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetesTargeted disruption of PDE3B, but not PDE3A, protects murine heart from ischemia/reperfusion injury.Obesity, immunomodulation and chronic kidney disease.Lipoxin a4 preconditioning and postconditioning protect myocardial ischemia/reperfusion injury in ratsDipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome.Lipid effects and cardiovascular disease risk associated with glucose-lowering medications.Mast Cell and M1 Macrophage Infiltration and Local Pro-Inflammatory Factors Were Attenuated with Incretin-Based Therapies in Obesity-Related Glomerulopathy.Cyclic AMP-mediated pleiotropic effects of glucagon-like peptide-1 receptor activation. Focus on "Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a".PTEN upregulation may explain the development of insulin resistance and type 2 diabetes with high dose statins.
P2860
Q34538482-11EEBF8B-2B48-4191-B37C-F24EA38B4072Q34994502-C6C7E8EB-FBFF-4631-B99D-9F9DA16C11AAQ35567034-F82DF582-926D-4814-8671-AEE7695009D8Q35640634-C410A775-1817-41BF-A5C6-F1D6E465CA02Q37061899-80FC607B-CB00-4417-B254-37CA85409DA2Q37177528-AA18AFFA-DAF3-41CE-9B88-DDEC1EEC3FA2Q38511039-6CBE30D4-B0D7-4FCC-A429-9F8BB8FEB421Q41557819-7E673399-27E9-4600-A308-4D1E16863537Q44084499-CFD4BD68-9293-4AD0-AD3A-7B4E4D534F9FQ51317623-6B740BD5-7B35-48A2-86C1-92FAC7E72DF0
P2860
Phosphodiesterase-3 inhibition augments the myocardial infarct size-limiting effects of exenatide in mice with type 2 diabetes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Phosphodiesterase-3 inhibition ...... in mice with type 2 diabetes.
@en
Phosphodiesterase-3 inhibition ...... in mice with type 2 diabetes.
@nl
type
label
Phosphodiesterase-3 inhibition ...... in mice with type 2 diabetes.
@en
Phosphodiesterase-3 inhibition ...... in mice with type 2 diabetes.
@nl
prefLabel
Phosphodiesterase-3 inhibition ...... in mice with type 2 diabetes.
@en
Phosphodiesterase-3 inhibition ...... in mice with type 2 diabetes.
@nl
P2093
P2860
P1476
Phosphodiesterase-3 inhibition ...... in mice with type 2 diabetes.
@en
P2093
Alexander C Castillo
Hongmei Ye
Jinqiao Qian
Jose R Perez-Polo
Mandeep Bajaj
Shukuan Ling
Yochai Birnbaum
P2860
P304
P356
10.1152/AJPHEART.00609.2012
P577
2012-10-26T00:00:00Z